Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | The impact of post-transplant maintenance strategies on the QoL of patients with multiple myeloma

Nico Gagelmann, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, explains the post-transplant maintenance strategies for myeloma patients in terms of quality of life (QoL). Not all patients tolerate the standard of care lenalidomide, so clinical studies must consider a multi-agent maintenance approach without neglecting QoL, especially if this treatment will not significantly prolong overall survival (OS). This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.